Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001062993-22-004800 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-16 | ORGO | Bilbo Patrick | COO | F - Tax | $7.78 | -937 | 185.7K | -0.5% | -$7,290 |
| D | 2022-02-17 | 2022-02-15 | ORGO | Bilbo Patrick | COO | A - Grant | $0.00 | +52.9K | 186.6K | +40% | $0 |
| D | 2022-02-17 | 2022-02-15 | ORGO | Bilbo Patrick | COO | A - Grant | $0.00 | +125.5K | 125.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-16 | F | D | 937 | $7.78 | 185,659 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-02-15 | A | A | 52,926 | $0.00 | 186,596 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-02-15 | A | A | 125,522 | $0.00 | 125,522 | D | $8.03 · — to 2032-02-15 | 125,522 Class A Common Stock | (F2) The option becomes exercisable in equal annual installments over four years beginning February 15, 2022. |